CDK1 and obstructive sleep apnea syndrome: Consistent with results of the cell cycle analysis, while ENFX appeared less potent than CPFX, it was still effective at reducing the cdc2 expression in canine OSA cells; most notable at a concentration of 40 μg/ml on day 5 (Figure 3).